Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Atten Disord ; 25(1): 53-62, 2021 01.
Article in English | MEDLINE | ID: mdl-29671360

ABSTRACT

Objective: Continuous performance tests (CPTs) usually utilize visual stimuli. A previous investigation showed that inattention is partially independent of modality, but response inhibition is modality-specific. Here we aimed to compare performance on visual and auditory CPTs in ADHD and in healthy controls. Method: The sample consisted of 160 elementary and high school students (43 ADHD, 117 controls). For each sensory modality, five variables were extracted: commission errors (CEs) and omission errors (OEs), reaction time (RT), variability of reaction time (VRT), and coefficient of variability (CofV = VRT / RT). Results: The ADHD group exhibited higher rates for all test variables. The discriminant analysis indicated that auditory OE was the most reliable variable for discriminating between groups, followed by visual CE, auditory CE, and auditory CofV. Discriminant equation classified ADHD with 76.3% accuracy. Conclusion: Auditory parameters in the inattention domain (OE and VRT) can discriminate ADHD from controls. For the hyperactive/impulsive domain (CE), the two modalities are equally important.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Adolescent , Attention , Attention Deficit Disorder with Hyperactivity/diagnosis , Child , Humans , Impulsive Behavior , Neuropsychological Tests , Reaction Time
2.
Pain Physician ; 19(2): E319-27, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26815259

ABSTRACT

BACKGROUND: There is experimental evidence that dexmedetomidine has neuroprotective effects. So, it could be expected that its intrathecal or epidural administration presents no harm. However, whether dexmedetomidine is neurotoxic to the spinal cord remains to be fully elucidated. OBJECTIVE: To evaluate the effect of preservative-free dexmedetomidine administered as a subarachnoid single injection on the spinal cord and meninges of rabbits. STUDY DESIGN: Research article. SETTING: Experimental research laboratory. METHODS: Twenty young adult female rabbits, each weighing between 3200 and 4900 g, and having a spine length between 36 and 40 cm, were divided by lot into 2 groups (G): 0.9% saline in G1 and preservative-free dexmedetomidine in G2 (dose of 10 µg). After intravenous anesthesia with ketamine and xylazine, the subarachnoid space was punctured at S1-S2 under ultrasound guidance, and a random 5 µl.cm-1 of spinal length (0.2 mL) of solution (saline or dexmedetomidine) was injected. The animals remained in captivity for 21 days under medical observation and were sacrificed by decapitation. The lumbosacral spinal cord portion was removed for immunohistochemistry to assess the glial fibrillary acidic protein (GFAP), and histology was assessed using hematoxylin and eosin (HE) stain. RESULTS: None of the animals had impaired motor function or decreased nociception during the period of clinical observation. None of the animals from the control group showed signs of injuries to meninges. In the dexmedetomidine group, however, 9 animals presented with signs of meningeal injury. The main histological changes observed were areas with meningeal thickening and lymphoplasmocitary infiltration in the pia-mater and arachnoid. Further histological examination also revealed adherence areas among the pia and arachnoid. There was no signal of injury in neural tissue in any animal of both groups. LIMITATIONS: Evaluation of the possible analgesic effects of the intrathecal dexmedetomidine was not performed. CONCLUSION: On the basis of the present results, dexmedetomidine administered in the subarachnoid space in a single dose of 10 µg is capable of producing histological changes over the meninges of rabbits.


Subject(s)
Analgesics, Non-Narcotic/administration & dosage , Dexmedetomidine/administration & dosage , Spinal Cord/drug effects , Analgesics, Non-Narcotic/adverse effects , Animals , Dexmedetomidine/adverse effects , Disease Models, Animal , Female , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry , Injections, Spinal/adverse effects , Injections, Spinal/methods , Meninges/drug effects , Motor Skills/drug effects , Nociception/drug effects , Rabbits , Spinal Cord/metabolism , Spinal Cord/pathology , Subarachnoid Space/drug effects
3.
J Oral Pathol Med ; 43(7): 499-506, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24527751

ABSTRACT

BACKGROUND: CD44 and aldehyde dehydrogenase 1 (ALDH1) are considered putative markers of highly tumorigenic cells (i.e., cancer stem-like cells) in head and neck squamous cell carcinomas. This small subset of cells is believed to be the primary responsible for tumor initiation and progression. The objectives of this study were (i) to evaluate the patterns of CD44 and ALDH1 expression in the tumor center and in the invasive front, as well as in adjacent non-tumor epithelium, and (ii) to correlate these findings with clinical parameters. MATERIALS AND METHODS: The sample comprised 44 patients with primary head and neck squamous cell carcinomas. Hematoxylin and eosin (HE) staining was used for histopathological tumor grading and for morphological analysis of adjacent non-tumor epithelium. Semiquantitative analysis was performed in histological sections immunostained for CD44 and ALDH1. RESULTS: ALDH1 immunostaining in the invasive front showed positive association with tumor size, regional metastasis, tumor histopathological grading, and disease progression. Moreover, expression of this marker in both tumor invasive front and adjacent non-tumor epithelium was related with more aggressive tumors. CD44 immunostaining was heterogeneous in all areas evaluated and did not show association with clinical data. CONCLUSION: Collectively, these data suggest that ALDH1 immunostaining in the invasive front and in adjacent non-tumor epithelium may help identify tumors with a more aggressive behavior, potentially contributing to improving treatment customization and the monitoring of patients with head and neck cancer.


Subject(s)
Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Neoplastic Stem Cells/pathology , Adult , Aged , Aldehyde Dehydrogenase 1 Family , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/secondary , Disease Progression , Disease-Free Survival , Epithelium/pathology , Female , Follow-Up Studies , Humans , Hyaluronan Receptors/analysis , Hyperplasia , Isoenzymes/analysis , Male , Middle Aged , Mouth Neoplasms/pathology , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Precancerous Conditions/pathology , Retinal Dehydrogenase/analysis , Survival Rate , Treatment Outcome
4.
Rapid Commun Mass Spectrom ; 19(12): 1703-8, 2005.
Article in English | MEDLINE | ID: mdl-15912471

ABSTRACT

Characterization of the peptide content in snake venoms can be an important tool for the investigation of new pharmacological lead compounds. For this purpose, single-step analysis of crude venoms has recently been demonstrated using mass spectrometry (MS) techniques. Reproducible profiles of ions in MS and MS/MS spectra may also be used to compare venoms from different species. In this work matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) was used to obtain mass patterns of the major peptides (<8 kDa) found in pooled venoms from the genera Bothrops and Crotalus. Venoms from five different Bothrops species (B. jararaca, B. insularis, B. alternatus, B. jararacussu, and B. neuwiedi) and three Crotalus species (C. viridis, C. adamanteus and C. durissus terrificus) were analyzed. In agreement with other reports, venoms from Bothrops species contained a variety of peptides in the range m/z 1000-1500, and in some samples larger components (m/z 7000-8000) were detected. In the Crotalus species venoms were rich in peptides ranging from m/z 1000-1500 and 4000-5500. MS/MS experiments on the low molecular mass peptides (m/z 1000-1500) confirmed the presence of ten new bradykinin-potentiating peptides among venoms from genera Bothrops and Crotalus. In order to determine whether additional peptides could be identified after partial purification, B. jararaca venom was subjected to size-exclusion chromatography on Sephacryl S-200, and two distinct low molecular mass pools were analyzed further by MALDI-TOFMS. No additional peptides were detected from the pool with masses below 2000 Da but a substantial improvement with better resolution was observed for the pool with masses above 7000 Da, indicating that complex samples such as crude snake venoms can be analyzed for low molecular mass peptides using a single-step procedure.


Subject(s)
Bothrops , Crotalid Venoms/chemistry , Peptides/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Amino Acid Sequence , Animals , Chromatography, Gel/methods , Ion Exchange Resins/chemistry , Molecular Sequence Data , Molecular Weight , Peptides/isolation & purification , Reproducibility of Results , Sequence Analysis, Protein
5.
Rev. bras. ortop ; 31(8): 620-4, ago. 1996. tab, graf
Article in Portuguese | LILACS | ID: lil-212555

ABSTRACT

Foi estudado em laboratório o comportamento biomecânico do fixador externo de Ilizarov, utilizando-se duas configuraçoes espaciais submetidas a ensaios de forças de compressao axiais centrais e excêntricas. As montagens foram instaladas em corpo de teste, simulando fratura instável do terço médio da tíbia. Foram avaliados o deslocamento axial do corpo de teste, os deslocamentos radiais de seus segmentos, a distância máxima observada entre estes segmentos nos planos perpendiculares ao axial e as deformaçoes das montagens à aplicaçao das forças. Os resultados obtidos permitem afirmar que o fixador externo de Ilizarov funciona em regime de dinamizaçao axial e que, do ponto de vista biomecânico, pode ser considerado como associaçao de molas em paralelo.


Subject(s)
Biomechanical Phenomena , Ilizarov Technique/instrumentation , Compressive Strength , Evaluation Study
SELECTION OF CITATIONS
SEARCH DETAIL